Fish Oil Supplementation, Resting Energy Expenditure, Skeletal Muscle Membrane Composition and Metabolism in Elderly Subjects.
NCT02338401 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2017-05-04
Summary
Resting metabolic rate (RMR) declines by 1-2% per decade after 20 years of age. This reduction is linked to a decrease in fat free mass (FFM) (10-20%) and the rate of energy expenditure of tissues (Manini 2010).
It has also been shown that as we age there is a:
* Concomitant reduction in basal fat and carbohydrate oxidation, most likely due to the decrease in RMR than to a change in respiratory exchange ratio (RER) (St-Onge and Gallagher 2010).
* A change towards a more saturated membrane of different tissues (Rabini et al 2002).
Incorporation of omega-3s, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), into cell membranes may alter energy metabolism by:
* Increasing the rate at which proteins operate (Hulbert 2007).
* Promoting the release of EPA and DHA into the cytosol which will act as ligands for peroxisome proliferator-activated receptors (PPARs) (Calder 2011). PPARs play an important role in energy homeostasis by regulating genes involved in lipid metabolism (Kota et al 2005).
* Augmenting protein synthesis through activation of the mTOR-p70s6k pathway (Di Girolamo et al 2014).
Supplementation with fish oil in older males and females:
* Increases whole muscle phospholipid profile of EPA and DHA (Smith et al 2011).
* Increases lean body mass (LBM), RMR, and fatty acid oxidation (Logan et al unpublished)
* Decreases carbohydrate oxidation (Logan et al unplubished). Skeletal muscle (SM) accounts for 20-30% of RMR (Zurlo et al 1990, Manini 2010), therefore it is tempting to speculate that these changes may occur by some of the mechanisms described earlier, with skeletal muscle being an important contributor.
To date there are no studies that have examined the effect of n-3 supplementation (3g/day)\* on plasma membrane fatty acid composition, RMR and substrate oxidation, and the possible mechanisms behind it.
Therefore the purpose of this study is to determine whether in older adults (female and male), supplementation with n-3 alters:
1. RMR and fatty acid oxidation.
2. Membrane composition of whole muscle and sarcolemma.
3. Content of skeletal muscle membrane fatty acid transport proteins.
4. Dose response of NaKATPase and SERCA efficiency
5. Content of mitochondrial proteins
6. Expression and content of PPARs and proteins involved in translocation of FA transporters (AMPK, ERK1/2, CamKII).
7. Phosphorylation of AMPKα(THR172), ERK1/2(THR202 TYR204) and CaMKII(THR286).
8. Proteomic profile of skeletal muscle.
9. Body composition
Conditions
- Whole Body and Skeletal Muscle Energy Metabolism
Interventions
- DIETARY_SUPPLEMENT
-
Omega-3 Complete
Fish Oil Capsules
- DIETARY_SUPPLEMENT
-
Placebo Pill
Olive Oil Capsules
Sponsors & Collaborators
-
University of Guelph
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 60 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-12-31
- Primary Completion
- 2017-06-30
- Completion
- 2017-09-30
Countries
- Canada
Study Locations
More Related Trials
-
Time Course Change in Skeletal Muscle and Blood Phospholipid Composition With Omega-3 Fatty Acid Supplementation
NCT05971147 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Fatty Acids to Combat Sarcopenia
NCT02103842 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Omega-3 Supplementation on Muscle Functioning, Inflammation and Muscle Signaling
NCT03986307 ·Status: COMPLETED ·Phase: NA
-
Effect of Combined Fatty Acid Supplementation and Eccentric Exercise Training on Exercise Performance
NCT03259412 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study Regarding the Beneficial Effects of Omega-3 Fatty Acids on Cardiometabolic Health
NCT02042274 ·Status: COMPLETED ·Phase: NA
-
n3 PUFA and Muscle-disuse Atrophy in Young Women
NCT03059836 ·Status: COMPLETED ·Phase: NA
-
Dietary Supplementation With Omega-3 Fatty Acid in Muscle Response
NCT03462771 ·Status: UNKNOWN ·Phase: NA
-
Fish Oil and Muscle Function
NCT01308957 ·Status: COMPLETED ·Phase: NA
-
Comparison of EPA and DHA-Rich Fish Oils on Lipoprotein Metabolism In Adults
NCT02514070 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Omega-3 Fatty Acids on Bone and Frailty
NCT00634686 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact of Fish Oil Dose on Tissue Content and Function
NCT04772040 ·Status: COMPLETED ·Phase: NA
-
A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss
NCT00094562 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Fish Oil on Patients With Chronic Nonspecific Low Back Pain
NCT02774109 ·Status: COMPLETED ·Phase: NA
-
Effects of Fish Oils on Inflammation and Insulin Resistance
NCT00579436 ·Status: COMPLETED ·Phase: NA
-
Short Term Omega-3 Supplementation on Performance
NCT02014233 ·Status: COMPLETED ·Phase: NA
-
Muscle Recovery After Omega-3 Supplementation
NCT07237113 ·Status: COMPLETED ·Phase: NA
-
Effect of High Omega-3 Fish Intake on Lipid Peroxidation
NCT01183520 ·Status: COMPLETED ·Phase: NA
-
Vitamin D and Omega-3 Inhibit Metabolic Syndrome
NCT01326442 ·Status: COMPLETED ·Phase: PHASE3
-
Metabolic Actions of Omega-3 Fatty Acids
NCT01896414 ·Status: COMPLETED ·Phase: NA
-
Meta-analysis of Fish Oil Supplementation and Cardiovascular Outcomes in Diabetes
NCT04327713 ·Status: UNKNOWN
-
Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers
NCT00682318 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Enhancing Adaptations to Exercise
NCT03350906 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of 4 Weeks Fish Oil Supplementation on Cycling Performance in Healthy Male Cyclists
NCT03205241 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Fatty Acids, the Omega-3 Index, and Atherosclerosis
NCT00886704 ·Status: COMPLETED ·Phase: NA
-
Cardiometabolic Benefits of Omega-3 Polyunsaturated Fatty Acids
NCT03378232 ·Status: COMPLETED ·Phase: NA